FDA applies four factors to determine whether a compounded drug is essentially a copy of a commercially available product: Same active ingredient semaglutide or tirzepatide Same route of administration subcutaneous injection Same dosage form injectable solution Same strength matching FDA-approved doses (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg, etc.) If your compounded product meets these four criteria, it is essentially a copy of Ozempic, Wegovy, Mounjaro, or Zepbound and it is illegal to compound, prescribe, or dispense
Step 1: Consult Your GP Your GP is your first port of call
Instead of letting an illness sideline you for a week or more, give your body the direct support it needs to get back on its feet faster
El Tesamorelin often presents itself as the king of burning abdominal fat, but how does it really compare to its competitors
Understanding each peptides receptor action, potency, and duration lets researchers pick the compound that fits their study goals
Maybe it feels like a band-aid instead of a real solution
